Dr. Arthur C. Lee, MD

Dr. Lee practices at The Cardiac & Vascular Institute in Gainesville, Florida.

Dr. Lee's NPI, 1063447977, was assigned on July 11, 2006. Dr. Lee graduated from Icahn School Of Medicine At Mount Sinai in 1997. Dr. Lee holds Florida license ME90119.

Dr. Lee's primary practice is The Cardiac & Vascular Institute, at 4645 NW 8th Ave, Gainesville, FL 32605 in Alachua County. The practice phone is (352) 264-2500.

Dr. Lee's primary practice is The Cardiac & Vascular Institute in Gainesville, Florida. Dr. Lee is also affiliated with UF Health Shands Hospital. The medical group on file is The Cardiac & Vascular Institute. Dmand AI also links Dr. Lee to 3 more hospitals and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Lee is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Lee's licenses on file in 2 states: Florida and New York.

Dmand AI lists angioplasty, cardiac catheterization, leg revascularization, pacemaker replacement and varicose vein treatment among the conditions Dr. Lee treats.

CMS data shows 5,368 Medicare services from Dr. Lee across 51 procedure codes in 2024, for 1,333 Medicare patients. Medicare paid $526,808 for them.

CMS counts 1,333 Medicare patients who saw Dr. Lee in 2024. The largest group is 75 to 84, with 573 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 71, with 51% women.

In 2024, Dr. Lee wrote 3,714 Medicare Part D claims for 596 patients. 64% of them were for generic drugs. CMS names the drug for 3,496 of them, across 38 drugs with 11 or more claims each, at $1,032,915 in total drug cost. In 2023, CMS named 3,190 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Lee for performance year 2024, reported as part of a group. Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth. CMS counts 40 procedures of leg revascularization (restoring blood flow) by Dr. Lee, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 18 papers to Dr. Lee, published from 2015 to 2020. 2016 was the busiest year, with 3. The most frequent topics are Atherectomy, Coronary, Coronary Artery Disease and Percutaneous Coronary Intervention. Dr. Lee has published most often in Catheter Cardiovasc Interv. Dr. Lee's most frequent co-authors are Richard A. Shlofmitz, MD, Michael Sunghoon Lee, MD and Jeffrey Warren Moses, MD.

Dmand AI links Dr. Lee to 9 clinical trials. 1 is still active or recruiting. Conditions studied include Peripheral Arterial Disease, Peripheral Vascular Diseases and Chronic Limb-Threatening Ischemia. LimFlow, Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Lee that name 2 trials.

CMS Open Payments shows 3,418 general payments to Dr. Lee from 89 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Amgen Inc. paid the most, $697,636. It also lists 19 research payments totaling $30,659 from 2016 to 2021, naming 2 clinical trials.

Dmand AI lists 1 award for Dr. Lee.

Dr. Lee graduated from Icahn School Of Medicine At Mount Sinai in 1997. Dr. Lee is a member of ACC.

Dr. Lee is in network with 16 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.